# Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trial
> Nurdin A.

URL kanonis: https://discover.unhas.ac.id/publications/immunogenicity-and-safety-of-sars-cov-2-recombinant-protein-subunit-vaccine-indo
Jurnal / Konferensi: Vaccine
Tahun terbit: 2024
DOI: https://doi.org/10.1016/j.vaccine.2024.03.077
ISSN: 0264410X
Kuartil SJR: Q1
Citations: 11

## Authors
- Nurdin A.

## Abstract
IndoVac in adults showed favourable safety profile and elicited non-inferior immune response to Covovax. (ClinicalTrials.gov: NCT05433285, Indonesian Clinical Research Registry: INA-R5752S9).

## Keywords
- Immunogenicity
- Medicine
- Virology
- Alum
- Adjuvant
- Recombinant DNA
- Immunology
- Antibody
- Biology
- Chemistry
- Organic chemistry
- Biochemistry
- Gene

---
Sumber: Discover Unhas — RIMS Universitas Hasanuddin.
Saat mengutip, gunakan DOI bila tersedia atau URL kanonis di atas.